Deletion and nonsynnonymous mutation data of Interferon (IFN), defensin (DEF), CDKN2A and PTEN in 17 TCGA cancer types

1. BLCA : Bladder Urothelial Carcinoma
2. BRCA : Breast invasive carcinoma
3. ESCA : Esophageal carcinoma
4. GBM : Glioblastoma multiforme
5. HNSC : Head and Neck squamous cell carcinoma
6. LGG : Brain Lower Grade Glioma
7. LIHC : Liver hepatocellular carcinoma
8. MESO : Mesothelioma
9. OV : Ovarian serous cystadenocarcinoma
10. PAAD : Pancreatic adenocarcinoma
11. PRAD : Prostate adenocarcinoma
12. SARC : Sarcoma
13. SKCM : Skin Cutaneous Melanoma
14. STAD : Stomach adenocarcinoma
15. UCS : Uterine Carcinosarcoma
16. Colorectal (COAD & READ): Colon adenocarcinoma & Rectum adenocarcinoma
17. Lung (LUAD & LUSC): Lung adenocarcinoma & Lung squamous cell carcinoma

• Column 1: TCGA patient ID

• Column 2: Homo deletion status of interferons and defensins

  • I: Homozygous deletion of interferons
  • D: Homozygous deletion of defensins
  • C: Co-occurring homozygous deletion of Interferon and defensins
  • N: Other

• Column 3-4: Homo deletion status of CDKN2A and PTEN

  • -2: Deep deletion (homozygous deletion)
  • -1: Shallow deletion (loss)
  • 0: No change (copy neutral)
  • 1: Copy gain
  • 2: Amplification

• Column 5-8: Mutation status of CDKN2A, PTEN, defensin and interferon

  • 0: no mutation
  • 1: nonsynonymous mutation